Adynxx Inc (ADYX)
0.00
USD |
OTCM |
Apr 24, 16:00
Adynxx Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2019 | -83.72% |
| December 31, 2018 | 24.13% |
| September 30, 2018 | -3.74% |
| June 30, 2018 | 31.37% |
| March 31, 2018 | 23.35% |
| December 31, 2017 | 23.91% |
| September 30, 2017 | 19.84% |
| June 30, 2017 | 16.72% |
| March 31, 2017 | 63.27% |
| December 31, 2016 | 64.93% |
| September 30, 2016 | 63.25% |
| June 30, 2016 | 64.20% |
| March 31, 2016 | 59.82% |
| December 31, 2015 | 60.21% |
| September 30, 2015 | 65.69% |
| June 30, 2015 | 52.17% |
| March 31, 2015 | 42.90% |
| December 31, 2014 | 46.72% |
| September 30, 2014 | 38.69% |
| June 30, 2014 | 19.35% |
| Date | Value |
|---|---|
| March 31, 2014 | -6.96% |
| December 31, 2013 | -15.17% |
| September 30, 2013 | -31.10% |
| June 30, 2013 | 3.87% |
| March 31, 2013 | -15.63% |
| December 31, 2012 | -22.24% |
| September 30, 2012 | -20.68% |
| June 30, 2012 | -71.90% |
| March 31, 2012 | -130.9% |
| December 31, 2011 | -146.8% |
| September 30, 2011 | -14.58% |
| June 30, 2011 | 35.85% |
| March 31, 2011 | -23.11% |
| December 31, 2010 | -11.11% |
| September 30, 2010 | -72.07% |
| June 30, 2010 | -13.41% |
| March 31, 2010 | -88.66% |
| December 31, 2009 | -2.65% |
| September 30, 2009 | -1.48% |
| June 30, 2009 | -7.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |